Uncategorized

Larvotto Resources (ASX:LRV) has reported final results from its reverse circulation drilling program at the Clarks Gully deposit, which is part of the company’s Hillgrove Gold-Antimony Project in New South Wales. The results indicate the potential for resource expansion, with high-grade intercepts discovered beyond the current resource boundaries. The program, which included 59 drill holes […]

Vysarn (ASX:VYS) has finalised its acquisition of CMP Consulting Group, effective from 1 December 2024. The completion follows a Share Sale Agreement initially announced on 13 September 2024. CMP Consulting Group is an engineering firm specialising in the water industry. Vysarn provides water services and related infrastructure support to the mining, industrial and utilities sectors. 

TikTok has filed an emergency appeal to the US Supreme Court, seeking to delay a law that could force a nationwide ban of the app unless its Chinese parent company, ByteDance, divests its ownership before 19 January. ByteDance has previously said it has no plans to do so. The 19 January deadline would see TikTok

The US stock market has shown mixed results overnight. The Dow Jones Industrial Average fell for an eighth consecutive session—its longest losing streak since 2018. In contrast, the Nasdaq Composite surged to a new all-time high, driven by gains in major tech stocks. Broadcom was the standout performer, rising over 11%. Over the past five

Murray Cod Australia (ASX:MCA) has secured $43m in finance from Westpac and finalised the purchase of a property adjoining its Bilbul site near Griffith, New South Wales. The funding package includes a $30m term loan, a $10m overdraft facility, and a $3m equipment finance facility. According to MCA, the funds will be used to refinance

PYC Therapeutics (ASX:PYC) has nominated a fourth clinical drug candidate, PYC-002, targeting Phelan-McDermid Syndrome (PMS), a rare neurodevelopmental disorder with no current treatment options. The Perth-based biotechnology company is progressing PYC-002 into an Investigational New Drug (IND) pathway, with human trials expected to begin in the first half of 2026. The decision follows the successful

INOVIQ (ASX:IIQ) has completed a proof-of-concept (POC) study showing that exosomes—tiny vesicles released from cells—can be “weaponised” to target and kill breast cancer cells. Natural killers The process involves genetically engineering “natural killer” (NK) cells, which are a type of white blood cell that play a key role in the body’s immune system. The exosomes

BrainChip (ASX:BRN) has signed a commercial licensing agreement with Frontgrade Gaisler, a provider of radiation-hardened microprocessors. The deal will see BrainChip’s Akida AI intellectual property incorporated into Frontgrade Gaisler’s fault-tolerant microprocessors, which are designed for use in space missions. This follows an earlier collaboration announced in May 2024 in which BrainChip’s Akida technology was evaluated

icetana (ASX:ICE) has secured a $465,000 (US$300,000) software contract with Malaysia’s AE Security System, marking its first customer in the Malaysian market. The three-year agreement will see icetana’s AI video analytics software deployed at 1 Utama, Malaysia’s largest shopping mall. The software will be provided on a software-as-a-service (SaaS) basis, with payments structured as an

Honeywell International is exploring the potential separation of its aerospace business as part of a strategic review, following pressure from activist investor Elliott Investment Management to split the company. The industrial conglomerate announced on Monday that it will provide an update on its review during its fourth-quarter earnings report in January. Honeywell’s aerospace division, which